Erratum: DOCK4 deletion at 7q31.1 in a de novo acute myeloid leukemia with a normal karyotype (Cellular Oncology. (2013) 36: (437)) DOI 10.1007/s13402-013-0145-5.;DOCK4 deletion at 7q31.1 in a de novo acutemyeloid leukemia with a normal karyotype

Cellular Oncology

Volumn 36, Issue 5, 2013, Pages 395-403

  Kjeldsen, Eigil ^a   Veigaard, Christopher ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Cryptic 7q deletion; High resolution aCGHanalysis .DOCK4 gene expression; NK AML; Signaling pathways; Tumor suppressor gene

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; CASE REPORT; CHROMOSOME 7Q; CHROMOSOME DELETION; COMPARATIVE GENOMIC HYBRIDIZATION; DISEASE COURSE; DOCK4 GENE; FEMALE; GENE; GENE EXPRESSION; HUMAN; KARYOTYPE; LEUKEMIA CELL; MIDDLE AGED; PRIORITY JOURNAL;

CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; FEMALE; GTPASE-ACTIVATING PROTEINS; HUMANS; KARYOTYPING; LEUKEMIA, MYELOID, ACUTE; MIDDLE AGED;

EID: 84892700025     PISSN: 22113428     EISSN: 22113436     Source Type: Journal    
DOI: 10.1007/s13402-013-0145-5     Document Type: Erratum

References (45)

1. S.H. Swerdlow, WHO Classification of Tumours of Haematopoitic and Lymphoid Tissues, 4th edn. (International Agency for Research on Cancer (IARC), Lyon, 2008), pp. 109-147
2. D. Grimwade, R.K. Hills, A.V. Moorman, H. Walker, S. Chatters, A.H. Goldstone, K. Wheatley, C.J. Harrison, A.K. Burnett, Refinement of cytogenetic classification in acute myeloid leukemia: Determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. Blood 116, 354- 365 (2010)
3. C. Schoch, W. Kern, S. Schnittger, T. Buchner, W. Hiddemann, T. Haferlach, The influence of age on prognosis of de novo acute myeloid leukemia differs according to cytogenetic subgroups. Haematologica 89, 1082-1090 (2004)
4. K. Mrozek, H. Dohner, C.D. Bloomfield, Influence of new molecular prognostic markers in patients with karyotypically normal acute myeloid leukemia: Recent advances. Curr. Opin. Hematol. 14, 106- 114 (2007)
5. R. Mawad, E.H. Estey, Acute myeloid leukemia with normal cytogenetics. Curr Oncol Rep 14, 359-368 (2012)
6. K. Mrozek, G. Marcucci, P. Paschka, S.P. Whitman, C.D. Bloomfield, Clinical relevance ofmutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: Are we ready for a prognostically prioritized molecular classification? Blood 109, 431-448 (2007)
7. Z. Li, T. Herold, C. He, P.J. Valk, P. Chen, V. Jurinovic, U. Mansmann, M.D. Radmacher, K.S. Maharry, M. Sun, X. Yang, H. Huang, X. Jiang, M.C. Sauerland, T. Büchner, W. Hiddemann, A. Elkahloun, M.B. Neilly, Y. Zhang, R.A. Larson, M.M. Le Beau, M.A. Caligiuri, K. Döhner, L. Bullinger, P.P. Liu, R. Delwel, G. Marcucci, B. Lowenberg, C.D. Bloomfield, J.D. Rowley, S.K. Bohlander, J. Chen, Identification of a 24-gene prognostic signature that improves the European LeukemiaNet risk classification of acute myeloid leukemia: An international collaborative study. J. Clin. Oncol. 31, 1172-1181 (2013)
8. R. Basirico, R. Pirrotta, F. Fabbiano, S.Mirto, L. Cascio,M. Pagano, G. Cammarata, S. Magrin, A. Santoro, Submicroscopic deletions at region are associated with recurrent chromosome abnormalities in acute leukemia. Haematologica 88, 429-437 (2003)
9. V. Adema, J.M. Hernandez, M. Abaigar, E. Lumbreras, E. Such, A. Calull, E. Dominguez, L. Arenillas, M. Mallo, J. Cervera, I. Marugán, M. Tormo, F. García, T. González, E. Luño, C. Sanzo, M.L. Martín, M. Fernández, D. Costa, B. Blázquez, B. Barreña, F. Marco, A. Batlle, I. Buño, C. Martínez-Laperche, V. Noriega, R. Collado, D. Ivars, F. Carbonell, I. Vallcorba, J. Melero, E. Delgado, M.T. Vargas, J. Grau, M. Salido, B. Espinet, C. Melero, L. Florensa, C. Pedro, F. Solé, Application of FISH 7q in MDS patients without monosomy 7 or 7q deletion by conventional G-banding cytogenetics: Does - 7/7q- detection by FISH have prognostic value? Leuk. Res. 37, 416-421 (2013)
10. A. Tyybakinoja, E. Elonen, K. Piippo, K. Porkka, S. Knuutila, Oligonucleotide array-CGH reveals cryptic gene copy number alterations in karyotypically normal acute myeloid leukemia. Leukemia 21, 571-574 (2007)
11. R.N.Mackinnon, G. Kannourakis,M.Wall, L.J. Campbell, A cryptic deletion in 5q31.2 provides further evidence for a minimally deleted region in myelodysplastic syndromes. Cancer Genet 204, 187-194 (2011)
12. M.E. Mcnerney, C.D. Brown, X. Wang, E.T. Bartom, S. Karmakar, C. Bandlamudi, S. Yu, J. Ko, B.P. Sandall, T. Stricker, J. Anastasi, R.L. Grossman, J.M. Cunningham, M.M. Le Beau, K.P. White, CUX1 is a haploinsufficient tumor suppressor gene on chromosome 7 frequently inactivated in acute myeloid leukemia. Blood 121, 975- 983 (2013)
13. H. Makishima, M. Rataul, L.P. Gondek, J. Huh, J.R. Cook, K.S. Theil, M.A. Sekeres, E. Kuczkowski, C. O'keefe, J.P. Maciejewski, FISH and SNP-A karyotyping in myelodysplastic syndromes: Improving cytogenetic detection of del(5q), monosomy 7, del(7q), trisomy 8 and del(20q). Leuk. Res. 34, 447-453 (2010)
14. R. Bajaj, F. Xu, B. Xiang, K. Wilcox, A.J. Diadamo, R. Kumar, A. Pietraszkiewicz, S. Halene, P. Li, Evidence-based genomic diagnosis characterized chromosomal and cryptic imbalances in 30 elderly patients with myelodysplastic syndrome and acutemyeloid leukemia. Mol. Cytogenet. (2011). doi:10.1186/1755-8166-4-3
15. E. Kjeldsen, A.S. Roug, A novel unbalanced de novo translocation der(5)t(4;5)(q26;q21.1) in adult T-cell precursor lymphoblastic leukemia. Mol. Cytogenet. (2012). doi:10.1186/1755-8166-5-21
16. L. Grubach, C. Juhl-Christensen, A. Rethmeier, L.H. Olesen, A. Aggerholm, P. Hokland, M. Ostergaard, Gene expression profiling of Polycomb, Hox and Meis genes in patients with acute myeloid leukaemia. Eur. J. Haematol. 81, 112-122 (2008)
17. E.J. Johnson, S.W. Scherer, L. Osborne, L.C. Tsui, D. Oscier, S. Mould, F.E. Cotter, Molecular definition of a narrow interval at 7q22.1 associated with myelodysplasia. Blood 87, 3579-3586 (1996)
18. C.L. Andersen, A. Gruszka-Westwood, M. Ostergaard, J. Koch, E. Jacobsen, E. Kjeldsen, B. Nielsen, A narrow deletion of 7q is common to HCL, and SMZL, but not CLL. Eur. J. Haematol. 72, 390- 402 (2004)
19. P. Tripputi, B. Cassani, R. Alfano, D. Graziani, D. Cigognini, P. Doi, M. Bignotto, G. Corneo, G. Coggi, Chromosome 7 monosomy and deletions in myeloproliferative diseases. Leuk. Res. 25, 735-739 (2001)
20. H. Liang, J. Fairman, D.F. Claxton, P.C. Nowell, E.D. Green, L. Nagarajan, Molecular anatomy of chromosome 7q deletions in myeloid neoplasms: Evidence for multiple critical loci. Proc. Natl. Acad. Sci. U. S. A. 95, 3781-3785 (1998)
21. E.R. Velloso, L. Michaux, A. Ferrant, J.M. Hernandez, P. Meeus, J. Dierlamm, A. Criel, A. Louwagie, G. Verhoef, M. Boogaerts, J.L. Michaux, A. Bosly, C. Mecucci, H. van den Berghe, Deletions of the long arm of chromosome 7 in myeloid disorders: loss of band 7q32 implies worst prognosis. Br. J. Haematol. 92, 574-581 (1996)
22. P. Greenberg, C. Cox,M.M. Lebeau, P. Fenaux, P.Morel, G. Sanz, T. Vallespi, T.Hamblin, D. Oscier, K. Ohyashiki, K. Toyama, C.Aul,G. Mufti, J. Bennett, International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 89, 2079-2088 (1997)
23. M.M. Le Beau, R. Espinosa 3rd, E.M. Davis, J.D. Eisenbart, R.A. Larson, E.D. Green, Cytogenetic and molecular delineation of a region of chromosome 7 commonly deleted in malignant myeloid diseases. Blood 88, 1930-1935 (1996)
24. M.B. Gonzalez, N.C. Gutierrez, J.L. Garcia, E.F. Schoenmakers, F. Sole,M.J. Calasanz, J.F. SanMiguel, J.M. Hernandez, Heterogeneity of structural abnormalities in the 7q31.3 approximately q34 region in myeloid malignancies. Cancer Genet Cytogenet 150, 136-143 (2004)
25. S. Tosi, S.W. Scherer, G. Giudici, B. Czepulkowski, A. Biondi, L. Kearney, Delineation of multiple deleted regions in 7q in myeloid disorders. Genes Chromosomes Cancer 25, 384-392 (1999)
26. J. Kere, T. Ruutu, K.A. Davies, I.B. Roninson, P.C. Watkins, R. Winqvist, A. De La Chapelle, Chromosome 7 long arm deletion in myeloid disorders: A narrow breakpoint region in 7q22 defined by molecular mapping. Blood 73, 230-234 (1989)
27. S. Lewis, G. Abrahamson, J. Boultwood, C. Fidler, A. Potter, J.S. Wainscoat, Molecular characterization of the 7q deletion in myeloid disorders. Br. J. Haematol. 93, 75-80 (1996)
28. K. Fischer, S. Frohling, S.W. Scherer, J. Mcallister Brown, C. Scholl, S. Stilgenbauer, L.C. Tsui, P. Lichter, H. Dohner, Molecular cytogenetic delineation of deletions and translocations involving chromosome band 7q22 in myeloid leukemias. Blood 89, 2036-2041 (1997)
29. K.Döhner, J. Brown,U. Hehmann, C.Hetzel, J. Stewart,G. Lowther, C. Scholl, S. Fröhling, A. Cuneo, L.C. Tsui, P. Lichter, S.W. Scherer, H. Döhner,Molecular cytogenetic characterization of a critical region in bands 7q35-q36 commonly deleted in malignant myeloid disorders. Blood 92, 4031-4035 (1998)
30. D. Cigognini, G. Corneo, E. Fermo, A. Zanella, P. Tripputi, HIC gene, a candidate suppressor gene within a minimal region of loss at 7q31.1 in myeloid neoplasms. Leuk. Res. 31, 477-482 (2007)
31. L. Zhou, J. Opalinska, D. Sohal, Y. Yu, Y. Mo, T. Bhagat et al., Aberrant epigenetic and genetic marks are seen in myelodysplastic leukocytes and reveal Dock4 as a candidate pathogenic gene on chromosome 7q. J. Biol. Chem. 286, 25211-25223 (2011)
32. H. Liang, P.D. Castro, J. Ma, L. Nagarajan, Finer delineation and transcript map of the 7q31 locus deleted in myeloid neoplasms. Cancer Genet Cytogenet 162, 151-159 (2005)
33. V. Yajnik, C. Paulding, R. Sordella, A.I. Mcclatchey, M. Saito, D.C. Wahrer, P. Reynolds, D.W. Bell, R. Lake, S. van den Heuvel, J. Settleman, D.A. Haber, DOCK4, a GTPase activator, is disrupted during tumorigenesis. Cell 112, 673-684 (2003)
34. A. Jalali, H. Ebrahimi, M. Ohadi, M. Karimloo, A.I. Shemirani, B. Mohajer, H.R. Khorshid, New variations in the promoter regions of human DOCK4 and RAP1A genes, and coding regions of RAP1A in sporadic breast tumors. Avicenna J Med Biotechnol 1, 117-123 (2009)
35. J.C. Zenklusen, M. Oshimura, J.C. Barrett, C.J. Conti, Inhibition of tumorigenicity of amurine squamous cell carcinoma (SCC) cell line by a putative tumor suppressor gene on human chromosome 7. Oncogene 9, 2817-2825 (1994)
36. K.Hiramoto, M. Negishi, H. Katoh, Dock4 is regulated by RhoG and promotes Rac-dependent cell migration. Exp Cell Res 312, 4205- 4216 (2006)
37. J.F. Cote, K. Vuori, Identification of an evolutionarily conserved superfamily of DOCK180-related proteins with guanine nucleotide exchange activity. J Cell Sci 115, 4901-4913 (2002)
38. V.M. Braga, GEF without a Dbl domain? Nat Cell Biol (2002). doi: 10.1038/ncb0802-e188
39. J.F. Cote, K. Vuori, GEF what? Dock180 and related proteins help Rac to polarize cells in new ways. Trends Cell Biol. 17, 383-393 (2007)
40. N. Hiramoto-Yamaki, S. Takeuchi, S. Ueda, K. Harada, S. Fujimoto, M. Negishi, H. Katoh, Ephexin4 and EphA2 mediate cell migration through a RhoG-dependent mechanism. J Cell Biol 190, 461-477 (2010)
41. W.J. Pannekoek, M.R. Kooistra, F.J. Zwartkruis, J.L. Bos, Cell-cell junction formation: The role of Rap1 and Rap1 guanine nucleotide exchange factors. Biochim. Biophys. Acta 1788, 790-796 (2009)
42. J.C. Mulloy, J.A. Cancelas, M.D. Filippi, T.A. Kalfa, F. Guo, Y. Zheng, Rho GTPases in hematopoiesis and hemopathies. Blood 115, 936-947 (2010)
43. G. Upadhyay, W. Goessling, T.E. North, R. Xavier, L.I. Zon, V. Yajnik, Molecular association between beta-catenin degradation complex and Rac guanine exchange factor DOCK4 is essential for Wnt/beta-catenin signaling. Oncogene 27, 5845-5855 (2008)
44. K. Kawada, G. Upadhyay, S. Ferandon, S. Janarthanan, M. Hall, J.P. Vilardaga, V. Yajnik, Cell migration is regulated by platelet-derived growth factor receptor endocytosis. Mol. Cell. Biol. 29, 4508-4518 (2009)
45. D.G. Gilliland, Hematologic malignancies. Curr. Opin. Hematol. 8, 189-191 (2001)